Clinigen Share Discussion Threads

[fernagx] 11/10/2019 15:33

You don't know how to read and interpret financial statements.

The key one is the cashflow statement!!!!!

CASH IS KING!

[pennypincher5] 09/10/2019 22:24

Business is broken - acquisitions used to hide underlying business going backwards.

[davr0s] 09/10/2019 19:16

Yep I sold recently - trend broken

[pennypincher5] 09/10/2019 19:12

The organic growth is (4), the basic earnings per share has dropped from 22.9p (18) to 4p (19), profit after tax is a sixth of the previous year (5.2 vs 22.9) and the adjustments are eye watering - the marketing are shorting it - whist the CEO was awarded a huge pay rise in the previous year - time to drop this one

[fernagx] 03/10/2019 11:59

cfro - who is going to purchase CLIN though?

there are lots of sells going through - but I can't explain why.

It is one of the least shorted stocks on AIM.

[cfro] 03/10/2019 10:45

Now trading quite a bit lower than where the CFO purchased a chunk a few days ago.

Anybody else think like me that with the share price trading down here that we must be vulnerable to an outside bid?

[aishah] 20/9/2019 08:48

CFO added £34k worth yesterday

[pennypincher5] 20/9/2019 07:39

Acquisitions (CSM and proleukin), and Link business have performed but the core business performance looks weak and no explanation to why or how this will be reversed. Predicted FY20 performance also a concern so why the increase in share price?

[lomax99] 19/9/2019 13:28

Liked the comments on market opportunity and margin expansion.

[cfro] 19/9/2019 13:20

FD share purchase..

market reacting well to the results now. the decline of Foscavir sales are well known now and should more or less be factored in. Investors will likely now be looking beyond that.

Agree there are lots of adjusted numbers but it is best to look through these at the underlying business and business model.

[mfhmfh] 19/9/2019 10:57

Peel Hunt today reiterates buy rating and 1,390p target price

[davr0s] 19/9/2019 10:29

Only figure I'm interested in is the share price and that seems to be taking the RNS in its stride at the moment

[apad] 19/9/2019 08:16

Foscavir (big seller) continuing to decline through the first half of current year. Spent loads on acquiring new drugs and reorganising. More adjusted figures than I can cope with.
apad

[cfro] 19/9/2019 08:11

Operating Cashflow up 40% , divi up 20%

full year towards upper end of forecasts.

[cfro] 02/9/2019 12:00

I've been adding today. I am hoping its hit bottom here. Looking v cheap now especially compared to growth prospects.

[aishah] 23/8/2019 09:44

Maiden purchase today.

[lomax99] 22/8/2019 08:50

Stockopedia have this on a forward PE of sub 12 to YE June 2020. Added a few.

[aishah] 21/8/2019 15:09

Quite a drop off since May here. Brexit related?

[jurgenklopp] 16/7/2019 07:08

Pretty good update.

Onwards beyond a tenner !!

[jurgenklopp] 15/7/2019 09:23

Trading update this week I reckon - almost certainly tomorrow.

[mfhmfh] 27/3/2019 13:28

great news today IMO.

Peel Hunt today reiterates buy rating and 1,390 target price.

[jurgenklopp] 08/3/2019 15:08

Yup.
Nothing to worry about.
Indeed I bought a few more at 925.5 !!!

[mfhmfh] 08/3/2019 11:24

hopefully a health retrace on low volume.